Search results

Records found: 24  
Your query: Sysno = ("0184440" OR "0184417" OR "0184447" OR "0184408" OR "0184395" OR "0184396" OR "0184411" OR "0184435" OR "0184443" OR "0184439" OR "0184405" OR "0184393" OR "0184409" OR "0184407" OR "0184433" OR "0184436" OR "0184449" OR "0184451" OR "0184427" OR "0184438" OR "0184399" OR "0184415" OR "0184414" OR "0184444")
  1. TitleAlternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapy
    Author infoQiao-Xia Zhang ... [et al.]
    Co-authors Zhang Qiao-Xia
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1198-1208  : ilustr., grafy, obr., tab.
    MeSH Subject leukémia myeloidná akútna
    zostrih alternatívny
    miera prežívania
    línia bunková nádorová
    Subj. Headings štúdia experimentálna
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  2. TitleAnlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells
    Author infoYan Xu, Ji Zheng, Zhi-Ying Ye
    Author Xu Yan
    Co-authors Zheng Ji
    Ye Zhi-Ying
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1119-1128  : ilustr., fareb. grafy, obr.
    MeSH Subject nádory prostaty
    proteíntyrozínkinázy : antagonisty a inhibítory
    procesy nádorové
    línia bunková nádorová
    Subj. Headings anlotinib * štúdia experimentálna
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  3. TitleAssociation between BRAF expression in circulating tumor cells and the clinical feature of patients with multiple myeloma
    Author infoJu-Xian Tang ... [et al.]
    Co-authors Tang Ju-Xian
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1228-1236  : ilustr., fareb. obr., tab.
    MeSH Subject myelóm mnohopočetný
    proteíny protoonkogénové B-raf
    bunky nádorové cirkulujúce
    prognóza
    Subj. Headings vyhodnotenie súboru pacientov
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  4. TitleBRAF inhibition promotes ER stress-mediated cell death in uveal melanoma
    Author infoYinu Zhao ... [et al.]
    Co-authors Zhao Yinu
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1070-1078  : ilustr., fareb. obr.
    MeSH Subject melanóm
    autofágia
    proteíny protoonkogénové B-raf
    stres endoplazmatického retikula
    línia bunková nádorová
    Subj. Headings melanóm uveálny * mutácia BRAF V600E * štúdia experimentálna
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  5. TitleCAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity
    Subtitleminireview
    Author infoMartin Krejči ... [et al.]
    Co-authors Krejčí Martin
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1008-1018  : ilustr., obr., tab.
    MeSH Subject myelóm mnohopočetný : farmakoterapia
    imunoterapia adoptívna
    receptory antigénové chimérické : použitie terapeutické
    antigén B-buniek, maturačný
    výsledok liečby
    štúdie klinické ako téma
    Subj. Headings myelóm mnohopočetný relapsujúci/refraktérny * CAR-T cells (chimeric antigen receptor T cells) * účinnosť a bezpečnosť liečby
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  6. TitleCircular RNAs: novel regulators of resistance to systemic treatments in breast cancer
    Subtitleminireview
    Author infoXiao-Qiang Guo, Yu-Ming Hua
    Author Guo Xiao-Qiang
    Co-authors Hua Yu-Ming
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1019-1028  : ilust., obr., tab.
    MeSH Subject nádory prsníka
    RNA kruhová
    rezistencia lieková nádorová
    procesy patologické
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  7. TitleCorrelation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer
    Author infoKe Ma, Yan-Xin Li, Qian-Qian Guo
    Author Ma Ke
    Co-authors Li Yan-Xin
    Guo Qian-Qian
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1092-1100  : ilustr., fareb. grafy, obr., tab.
    MeSH Subject karcinóm pľúc, nemalobunkový
    makrofágy spojené s nádorom
    proteíny onkogénové
    systémy informačné
    Subj. Headings proteín MTA1 (metastasis-associated gene 1)
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  8. TitleDDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling
    Author infoQing Han ... [et al.]
    Co-authors Han Qing
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1154-1164  : ilustr., obr.
    MeSH Subject nádory prsníka
    receptor s diskoidínovou doménou, typ 1
    procesy nádorové
    línia bunková nádorová
    Subj. Headings expresia DDR1 * štúdia experimentálna
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  9. TitleDecreased expression of SVEP1 is closely related to a cancer stem cell-like phenotype and poor prognosis in hepatocellular carcinoma
    Author infoWe-Chen Gong ... [et al.]
    Co-authors Gong We-Chen
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1209-1216  : ilustr., fareb. obr., tab.
    MeSH Subject karcinóm hepatocelulárny
    imunohistochémia
    prognóza
    miera prežívania
    Subj. Headings expresia SVEP1 * vyhodnotenie súboru pacientov
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

  10. TitleEFEMP2 increases the invasion ability of cervival cancer cells by promoting EMT via the Raf/MEK/ERK signaling pathway
    Author infoNa Li, Guo-Xin Ji, Zi-Yan Yang
    Author Li Na
    Co-authors Ji Guo-Xin
    Yang Zi-Yan
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 720
    Source Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685. - Bratislava : AEPress , 2022 . - Vol. 69, no. 5 (2022), s. 1185-1197  : ilustr., obr., tab.
    MeSH Subject nádory krčka maternice
    onkogény
    procesy nádorové
    línia bunková nádorová
    myši inbredné BALB C
    Subj. Headings expresia EFEMP2 * štúdia experimentálna
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.